Success Factor 2: Increased cost-effectiveness of treatment and support.

  • Improving cost-effectiveness of treatment and supports for people with an intellectual disability and co-occurring psychotic illness, Dr R Cvejic, Prof J Trollor, Dr S Reppermund, Dr P Srasuebkul, A/Prof J Lappin, Prof J Curtis, Prof K Dean, Prof K Samaras, Prof P Ward, Dr M O’Donnell, Dr A Walker University of New South Wales –$100,000.

  • Evaluating the cost-effectiveness of programs, interventions, and services for people with psychosis, Dr. Kate Filia, Dr. Shuai Gao, and Cotton. Orygen –$100,000.
Funding Priority Research